Amgen (AMGN) Inventory (2009 - 2026)

Amgen (AMGN) has reported Inventory for 18 consecutive years, with $6.2 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Inventory fell 8.07% year-over-year to $6.2 billion; the TTM figure through Mar 2026 stood at $6.2 billion (down 8.07% YoY), while the FY2025 annual figure was $6.2 billion, down 11.05% from the prior year.
• Inventory came in at $6.2 billion for Q1 2026 at Amgen, down from $6.2 billion in the prior quarter.
• The five-year high for Inventory was $9.5 billion in Q4 2023, with the low at $4.4 billion in Q1 2022.
• Average Inventory over 5 years is $6.3 billion, with a median of $6.2 billion recorded in 2025.
• Across the five-year window, Inventory jumped 93.06% in 2023 and decreased 26.48% in 2024, its largest moves.
• Year by year, Inventory stood at $4.9 billion in 2022, then surged by 93.06% to $9.5 billion in 2023, then fell by 26.48% to $7.0 billion in 2024, then declined by 11.05% to $6.2 billion in 2025, then dropped by 0.63% to $6.2 billion in 2026.
• According to Business Quant data, Inventory over the past three periods registered $6.2 billion, $6.2 billion, and $6.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.